Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04498052 · ClinicalTrials.gov registry record · NA
Evaluation of a Scalable Decision Support and Shared Decision Making Tool for Lung Cancer Screening
A NA study, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 1,855
- Enrollment target
NCT04498052: Completed NA study, sponsored by University of Utah.
NCT04498052 is a NA study that has completed, run by University of Utah. The registered enrollment target is 1,855 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (32% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04498052, a NA study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,855 participants
- Enrollment target
Study Summary
The purpose of this project is to increase appropriate low-dose computed tomography (LDCT) lung cancer screening through the development and wide dissemination of patient-centered clinical decision support (CDS) tools that (1) are integrated with the electronic health record (EHR) and clinical workflows, (2) prompt for shared decision making (SDM) when patients meet screening criteria, and (3) enable effective SDM using individually-tailored information on the potential benefits and harms of screening. The study will promote standard of care that is endorsed by the Centers for Medicare \& Medicaid Services (CMS) and the US Preventive Services Task Force (USPSTF).
Primary Outcome
The LCS care gap was considered closed if one or more of the following events occurred: (1) LDCT completion in the past year, (2) completion of another chest CT in the past year, or (3) SDM documentation in the past 3 years for eligible patients. To assess population care-gap closure levels at the end of each study period, we estimated the care-gap closure status for all patients who had primary care visits in the 12 months preceding the last day of the period. Using structured EHR data, SDM was
Interventions
- OTHER EHR-integrated Shared Decision Making Tool and Clinical Decision Support for Lung Cancer Screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,855 participants |
| Start Date | 2020-08-23 |
| Est. Completion | 2024-12-04 |
| Phase | NA |
What the finished NCT04498052 record still lists
NCT04498052 is an interventional study that assigns participants to a tested intervention. Its 1,855 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (32% higher).
The record links to 0 conditions, and to 1 intervention - of which EHR-integrated Shared Decision Making Tool and Clinical Decision Support for Lung Cancer Screening is the first listed.
NCT04498052 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04498052 about?
NCT04498052 is a clinical study titled "Evaluation of a Scalable Decision Support and Shared Decision Making Tool for Lung Cancer Screening". The purpose of this project is to increase appropriate low-dose computed tomography (LDCT) lung cancer screening through the development and wide dissemination of patient-centered clinical decision support (CDS) tools that (1) are integrated with the electronic health record (EHR) and clinical workf...
What is the current status of trial NCT04498052?
This trial is currently completed. It is a NA study. The enrollment target is 1,855 participants. The study started on 2020-08-23. Estimated completion is 2024-12-04.
What interventions are being tested in trial NCT04498052?
The interventions under investigation include: EHR-integrated Shared Decision Making Tool and Clinical Decision Support for Lung Cancer Screening (OTHER).
Who is sponsoring clinical trial NCT04498052?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04498052's enrollment target sits among peer trials
1,855 56th of 2000 higher than 1,945 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06465810 · 1,850 participants
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- NCT06580080 · 1,850 participants · NA
Evaluation of Are You Ready?
- NCT06740630 · 1,840 participants · Phase 3
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
- NCT07203313 · 1,872 participants · NA
Evaluation of Aim to Play, a User-Friendly Digital Application for Teacher Skills Training and Physical Education Activities for 3-5 Grade Students
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI